Company Valuation: Sernova Biotherapeutics Inc

Data adjusted to current consolidation scope
Fiscal Period: October 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 326.4 234.5 243.9 81.33 59.26 41.54 - -
Change - -28.16% 3.99% -66.65% -27.14% -29.9% - -
Enterprise Value (EV) 326.4 234.5 235.1 75.79 63.76 41.54 41.54 41.54
Change - -28.16% 0.27% -67.77% -15.87% -34.85% 0% 0%
P/E -41.7x -8.89x -5.85x -2.5x -3x -4.4x -3.67x -2.2x
PBR - - 18.4x -6.28x -1.96x - - -
PEG - -0x -0.1x 0.1x 0.1x 0.1x -0.2x -0x
Capitalization / Revenue - - - - - - 16.6x 0.33x
EV / Revenue - - - - - - 16.6x 0.33x
EV / EBITDA - - - - - - - -
EV / EBIT -0x -0x -0x -0x -0x -4.52x -3.49x -2.2x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.03 -0.09 -0.13 -0.1 -0.05 -0.025 -0.03 -0.05
Distribution rate - - - - - - - -
Net sales 1 - - - - - - 2.5 127.8
EBITDA -6.669 -24.31 -40.06 -31.12 -14.68 - - -
EBIT 1 -6.937 -24.75 -40.5 -31.66 -15.02 -9.2 -11.9 -18.9
Net income 1 -6.966 -24.42 -39 -32.19 -15.74 -11.3 -13.9 -20.9
Net Debt - - -8.722 -5.544 4.503 - - -
Reference price 2 1.2500 0.8000 0.7600 0.2500 0.1500 0.1100 0.1100 0.1100
Nbr of stocks (in thousands) 261,133 293,125 320,857 325,325 395,037 377,643 - -
Announcement Date 14/02/22 26/01/23 29/01/24 23/12/24 19/12/25 - - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-4.4x - - - 29.15M
35.9x4.23x15.9x2.39% 188B
22.27x3.77x13.5x2.76% 126B
26.7x4.76x16.31x1.16% 118B
32x3.08x12.43x2.23% 92.48B
19.04x0.23x14.13x0.66% 68.51B
44.44x3.9x13.29x1.92% 59.39B
46.74x11.74x32.93x-.--% 55.48B
28.66x7.1x18x1.4% 49.62B
45.81x3.44x12.72x0.5% 35.17B
Average 29.72x 4.69x 16.58x 1.45% 79B
Weighted average by Cap. 31.84x 4.40x 16.01x 1.75%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Sernova Biotherapeutics Inc

Historical PBR trend

Valuation ratios - PBR - Sernova Biotherapeutics Inc

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Sernova Biotherapeutics Inc

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Sernova Biotherapeutics Inc

  1. Stock Market
  2. Stocks
  3. SVA Stock
  4. Valuation Sernova Biotherapeutics Inc